Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
Karyopharm fosters a fast-paced environment that rewards hard workers.
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
You feel valued at Karyopharm
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
Our team is highly collegial; we all strive to be high achievers, but aren't competitive with each other in a negative way.
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
The interpersonal relationships and the being empowered to "follow my passion" by exploring new professional responsibilities that I might not have any experience in.
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
The leadership team sets the company priorities in such a way that we're all clear on the core missions of the company and its portfolio.
Revisión
¿Qué es lo mejor de tu paquéte de compensación?
The company knows that the way you show appreciation in the 21st century is with a generous compensation package, and Karyopharm puts their money where their mouth is.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×